SEC Form 4 · accession 0001221559-15-000001
IMPLANT SCIENCES CORP · IMSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Safir
Director
Period of report
Apr 16, 2015
Accepted (ET)
Apr 20, 2015 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001068874
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 16, 2015 | M | 200,000 | $0.08 | A | 200,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (Right to Buy)F1 | $0.08 | Apr 16, 2015 | M | 200,000 | D | — | May 22, 2019 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Option was fully exercisable 6/26/2010.